Clinical Trial Update: A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the effectiveness and safety of BMS-986322 in adults with moderate-to-severe psoriasis has completed. Results have been posted (2025-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• BMS-986322

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2025-11-25